Capital Research Global Investors
IDXX icon

Capital Research Global Investors’s Idexx Laboratories IDXX Stock Holding History

Capital Research Global Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415M Buy
789,111
+7,766
+1% +$4.36M 0.06% 180
2026
Q1 		$439M Buy
781,345
+173,591
+29% +$111M 0.07% 180
2025
Q4 		$411M Sell
607,754
-82,847
-12% -$56.4M 0.08% 162
2025
Q3 		$441M Buy
690,601
+5,641
+0.8% +$3.42M 0.08% 155
2025
Q2 		$367M Buy
684,960
+17,156
+3% +$8.2M 0.07% 167
2025
Q1 		$280M Buy
667,804
+51,808
+8% +$22.5M 0.06% 180
2024
Q4 		$255M Buy
615,996
+189,436
+44% +$83.1M 0.05% 198
2024
Q3 		$216M Buy
426,560
+349
+0.1% +$170K 0.04% 213
2024
Q2 		$208M Buy
426,211
+90,125
+27% +$45.2M 0.05% 211
2024
Q1 		$181M Buy
336,086
+91,225
+37% +$49.9M 0.04% 238
2023
Q4 		$136M Buy
+244,861
New +$115M 0.03% 255

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital Research Global Investors's IDXX Position: Q2 2026 in Review

Capital Research Global Investors increased its Idexx Laboratories (IDXX) stake by 0.99% in Q2 2026, buying an estimated $4.36M and bringing the position to 789,111 shares worth $415M. The position accounts for 0.06% of the portfolio, ranked #180.

Capital Research Global Investors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $441M in Q3 2025. 1,051 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Capital Research Global Investors held 789,111 shares of Idexx Laboratories worth $415M as of Q2 2026.
  • Capital Research Global Investors bought 7,766 Idexx Laboratories shares in Q2 2026, an estimated $4.36M.
  • Idexx Laboratories made up 0.06% of Capital Research Global Investors's portfolio in Q2 2026, its #180 holding.
  • Capital Research Global Investors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Capital Research Global Investors's Idexx Laboratories position peaked at $441M in Q3 2025.
  • 1,051 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.